Research & Development
Moderna pushes for COVID-19 vaccine boosters in older adults and high-risk individuals
12 October 2021 -

Moderna Inc (Nasdaq:MRNA) has said that the US Food and Drug Administration should authorise booster doses of its COVID-19 vaccine in fully vaccinated older adults and high-risk individuals, Reuters news agency reported on Tuesday.

The company said that its data supports the public health benefit of a booster dose of its vaccine to restore immune response, while reducing the number of "breakthrough" infections in fully-vaccinated adults.

Moderna's comments were released in briefing documents ahead of a Thursday and Friday meeting of the US FDA's outside expert advisers to discuss booster doses of Moderna and Johnson & Johnson's (NYSE:JNJ) COVID-19 vaccines.



Related Headlines